Overview
- 8 public-safe observations are available for this inspection.
- 6 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
5 Sep 2025
21 CFR 211.160(a)
Following/documenting laboratory controls
Cited by Roger F Zabinski, Homero W Aguilar
5 Sep 2025
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Roger F Zabinski, Homero W Aguilar
5 Sep 2025
21 CFR 211.192
Written record of investigation incomplete
Cited by Roger F Zabinski, Homero W Aguilar
5 Sep 2025
21 CFR 211.22(d)
Procedures not in writing, fully followed
Cited by Roger F Zabinski, Homero W Aguilar
Inspected site
CACentral Admixture Pharmacy Services, Inc.Phoenix, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(iv) | Cited across public-safe Form 483 observations | 1x |
Source document
PDF
PDF available
Form 483 source document
The source document is available to authorized Atlas users.
Full 483 report
Get the verbatim text of all 8 observations
The source PDF, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere